59 results
Page 2 of 3
8-K
EX-99.1
1xqw29y0nfy65rnutmgu
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-99.1
cmd3ju9npbabda2
4 Nov 21
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:40am
8-K
EX-99.1
gfawwwa05nm9hi30wga1
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
8-K
EX-99.1
7fcr83vwtme
9 Aug 21
Adaptimmune Reports Second Quarter Financial Results and Business Update
4:08pm
8-K
EX-99.1
xbkw39bsbvao xp
20 Nov 20
Regulation FD Disclosure
7:36am
8-K
EX-99.1
pdxd2hafo9j o5ij
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
8-K
EX-99.1
q53ux1fa
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
jvr2cufa
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-99.1
yvzsze0pajgn3ipb
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
55743 w8z8wfjnffv
27 Aug 19
Entry into a Material Definitive Agreement
8:39am